 |
|
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669. Published online 2020 Sep 25 DOI: https://doi.org/10.3350/cmh.2020.0163
|
|
Citations to this article as recorded by
 In‐depth assessment of steatotic liver disease awareness in high‐risk groups
Murat Özdede, Alper Tuna Güven, Burcu Çelik Eroğlu
Journal of Evaluation in Clinical Practice.2025;[Epub] CrossRef Association between menopause, body composition, and nonalcoholic fatty liver disease: A prospective cohort in northern China
Chenlu Yang, Shuohua Chen, Baoyu Feng, Ying Lu, Yanhong Wang, Wei Liao, Shouling Wu, Li Wang
Maturitas.2025; 192: 108148. CrossRef The efficacy of DASH combined with time-restricted feeding (16/8) on metabolic associated fatty liver disease management: a randomized controlled trial
Maryam Nilghaz, Amir Sadeghi, Glareh Koochakpoor, Hossein Poustchi, Navideh Khodadadi, Behnaz Narimani, Maryam Ghods, Mahshad Shafiee, Mohammad Reza Shahparvari, Azita Hekmatdoost
Scientific Reports.2025;[Epub] CrossRef Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches
Thea Chevalley, Marion Dübi, Laurent Fumeaux, Maria Serena Merli, Alexandre Sarre, Natacha Schaer, Umberto Simeoni, Catherine Yzydorczyk
Cells.2025; 14(6): 467. CrossRef Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death
Zsuzsa Muszka, Viktória Jenei, Rebeka Mácsik, Evgeniya Mezhonova, Silina Diyab, Réka Csősz, Attila Bácsi, Anett Mázló, Gábor Koncz
Cell Death & Disease.2025;[Epub] CrossRef The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD
Changhui Yu, Shiming He, Nan Peng, Maobin Kuang, Xin Huang, Chao Wang, Guotai Sheng, Wei Wang, Guobo Xie, Yang Zou
BMC Gastroenterology.2025;[Epub] CrossRef Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang
Clinical and Molecular Hepatology.2025; 31(2): 548. CrossRef Evaluating the regional and demographic variables in alcoholic liver disease-related mortality trends in the United States from 1999 to 2020: A cross sectional study
Malik Saad Hayat, Muhammad Mukarram Shoaib, Sara Sohail, Shahzaib Ahmed, Fatima Shahid, Hadia Ahmad, Mohammad Rayyan Naseer, Muhammad Mohtasham Shoaib, Raheel Ahmed
Medicine.2025; 104(14): e41988. CrossRef Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya
Preventive Medicine: Research & Reviews.2025; 2(4): 183. CrossRef Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights
Carlo Acierno, Fannia Barletta, Alfredo Caturano, Riccardo Nevola, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Luca Rinaldi
Nutrients.2025; 17(13): 2229. CrossRef Association of remnant cholesterol and newly diagnosed early‐onset type 2 diabetes mellitus in Chinese population: A retrospective cross‐sectional study
Wenjing Dong, Shiju Yan, Han Chen, Jian Zhao, Zengqiang Zhang, Weijun Gu
Journal of Diabetes.2024;[Epub] CrossRef Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
Metabolism.2024; 152: 155789. CrossRef Oxidative Balance Score and New-Onset Type 2 Diabetes Mellitus in Korean Adults without Non-Alcoholic Fatty Liver Disease: Korean Genome and Epidemiology Study-Health Examinees (KoGES-HEXA) Cohort
Mid-Eum Moon, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee
Antioxidants.2024; 13(1): 107. CrossRef The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: A concise review
Jong-Won Kim, Yu Ji Kim
Life Sciences.2024; 344: 122547. CrossRef Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou
Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions
Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan
Life Sciences.2024; 351: 122806. CrossRef Oxidative balance score as a useful predictive marker for new-onset type 2 diabetes mellitus in Korean adults aged 60 years or older: The Korean Genome and Epidemiologic Study–Health Examination (KoGES-HEXA) cohort
Mid-Eum Moon, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee
Experimental Gerontology.2024; 193: 112475. CrossRef Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters
Jiajun Qiu, Xin Huang, Maobin Kuang, Ruijuan Yang, Jiachong Li, Guotai Sheng, Yang Zou
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2583. CrossRef The newly proposed plasma-glycosylated hemoglobin A1c/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination popu
Shiming He, Song Lu, Changhui Yu, Maobin Kuang, Jiajun Qiu, Guotai Sheng, Yang Zou
BMC Gastroenterology.2024;[Epub] CrossRef Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD
Chun-Jen Liu, Wai Kay Seto, Ming-Lung Yu
Hepatology International.2024; 18(S2): 897. CrossRef Impact of Korean Military Service on the Prevalence of Steatotic Liver Disease: A Longitudinal Study of Pre-enlistment and In-Service Health Check-Ups
Jaejun Lee, Jae Hyeop Jung, Sung Jun Choi, Beomman Ha, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jeong-A Yu
Gut and Liver.2024; 18(5): 888. CrossRef The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective
Chao Wang, Xin Huang, Shiming He, Maobin Kuang, Guobo Xie, Guotai Sheng, Yang Zou
Lipids in Health and Disease.2024;[Epub] CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Maria Luisa Gambardella, Luigi Boccuto, Nahum Méndez-Sánchez, Francesco Luzza
Life.2024; 14(10): 1226. CrossRef Prevalence of metabolic dysfunction‐associated steatotic liver disease in people living with HIV and on antiretroviral treatment: A systematic review and meta‐analysis protocol
Amogelang Sedibe, Khanyisa Maswanganyi, Nomusa C. Mzimela, Mlindeli Gamede
Health Science Reports.2024;[Epub] CrossRef Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies
Naouras Bouajila, Cloé Domenighetti, Henri-Jean Aubin, Mickael Naassila
Frontiers in Epidemiology.2024;[Epub] CrossRef Dietary and nutrition considerations in caring for patients with nonalcoholic fatty liver disease: Updates for the practicing clinician
Carolyn Newberry, Sonal Kumar
Nutrition in Clinical Practice.2023; 38(1): 70. CrossRef The role of predicted lean body mass and fat mass in non-alcoholic fatty liver disease in both sexes: Results from a secondary analysis of the NAGALA study
Maobin Kuang, Ruijuan Yang, Qiyang Xie, Nan Peng, Song Lu, Guobo Xie, Shuhua Zhang, Yang Zou
Frontiers in Nutrition.2023;[Epub] CrossRef Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 179. CrossRef The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef Evaluation and analysis of novel germline variants in ethanol metabolism pathway genes predisposition to liver disease
Partha Pratim Das, Manash Jyoti Kalita, Anjan Jyoti Talukdar, Faraz Mohd Khan, Kalpajit Dutta, Simanta Kalita, Nabajyoti Goswami, Gautam Hazarika, Gourinath Samudrala, Mohammed ghaznavi Idris, Sangit Dutta, Subhash Medhi
Gene.2023; 873: 147451. CrossRef Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease
Jingfei Chen, Yingjie Su, Xin Su, Fei Luo
Diabetes Research and Clinical Practice.2023; 201: 110733. CrossRef MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis
Xiaojie He, Xinyue Huang, Yafang Qian, Ting Sun
Frontiers in Endocrinology.2023;[Epub] CrossRef Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
Min-Ji Kim, Jae-Hyung Roh, Jae-Han Jeon
Gut and Liver.2023; 17(4): 663. CrossRef The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
Jiajun Qiu, Maobin Kuang, Ruijuan Yang, Changhui Yu, Shiming He, Guotai Sheng, Yang Zou
Frontiers in Endocrinology.2023;[Epub] CrossRef Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study
Xinghui Li, Huijian Yang, Guobo Xie, Maobin Kuang, Guotai Sheng, Yang Zou
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef Old age as a risk factor for liver diseases: Modern therapeutic approaches
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
Experimental Gerontology.2023; 184: 112334. CrossRef Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia
Nutrients.2023; 15(23): 4997. CrossRef Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population
Jiawang Zou, Hailan Xiong, Huimin Zhang, Chong Hu, Song Lu, Yang Zou
BMC Gastroenterology.2022;[Epub] CrossRef Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease
Yang Zou, Chong Hu, Maobin Kuang, Yuliang Chai
BMC Gastroenterology.2022;[Epub] CrossRef MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 150. CrossRef Association between physical activity and insulin resistance using the homeostatic model assessment for insulin resistance independent of waist circumference
Tae Kyung Yoo, Byeong Kil Oh, Mi Yeon Lee, Ki-Chul Sung
Scientific Reports.2022;[Epub] CrossRef Effects of moderate ethanol consumption as a function of n-6:n-3 dietary ratio on lipid profile, inflammation, and liver function in mice
Kristine Giltvedt, Luciano S. Voutour, Brianna Tursellino, Alexandra Zella, Susan M. Brasser, Mee Young Hong
International Journal of Cardiology Cardiovascular Risk and Prevention.2022; 14: 200132. CrossRef Association between hypertriglyceridemic-waist phenotype and non-alcoholic fatty liver disease: a general population-based study
Ming Yang, Yaqin Xu, Chong Hu, Shuhua Zhang, Maobin Kuang, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou
BMC Gastroenterology.2022;[Epub] CrossRef Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population
Song Lu, Maobin Kuang, Jinjing Yue, Chong Hu, Guotai Sheng, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR‐mediated inhibition of autophagy under hyperlipidemic conditions
Heeseung Oh, Seung Yeon Park, Wonjun Cho, A. M. Abd El‐Aty, Ahmet Hacimuftuoglu, Chang Hyuk Kwon, Ji Hoon Jeong, Tae Woo Jung
Journal of Cellular Physiology.2022; 237(11): 4226. CrossRef The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
Maobin Kuang, Guotai Sheng, Chong Hu, Song Lu, Nan Peng, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clinical and Molecular Hepatology.2022; 28(4): 790. CrossRef Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population
Rongsheng Wang, Longlong DAI, Yanjia Zhong, Guobo Xie
Lipids in Health and Disease.2021;[Epub] CrossRef Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study
Yang Zou, Jianyun Lan, Yanjia Zhong, Shuo Yang, Huimin Zhang, Guobo Xie
Lipids in Health and Disease.2021;[Epub] CrossRef The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
Guotai Sheng, Song Lu, Qiyang Xie, Nan Peng, Maobin Kuang, Yang Zou
Lipids in Health and Disease.2021;[Epub] CrossRef Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
Wayne Eskridge, John M. Vierling, Wayne Gosbee, Gabriella A. Wan, May-Linh Hyunh, Henry E. Chang, Daisuke Tokuhara
PLOS ONE.2021; 16(11): e0260320. CrossRef
|